Wearable Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Wearable Medical Devices MarketTransparency Market Research is Published new Market Report “Wearable Medical Devices Market (Heart Rate Monitors, Activity Monitors, ECG, Pulse Oximeters, EEG, EMG, Glucose/Insulin Management, Pain Management, Wearable Respiratory Therapy) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019″ The global market for wearable medical devices was valued at USD 2.0 billion in 2012 and is expected to reach a value of USD 5.8 billion in 2019, growing at a CAGR of 16.4% from 2013 to 2019.

Wearable medical devices market defined in the strictest sense are devices with sensors attached to the body that detect and monitor changes in body signatures of various areas and organs. This report focuses on the various segments of wearable devices currently available in the market and also predicts the introduction of several innovative devices in the future. Healthcare segment forms a major part of the wearable technology market since the innovation of several applications in this area in the last two decades.

The meek wrist watch that was used to monitor only heart rate in the last decade has today been transformed into a powerful gadget that can today store vast quantities of data on patient information such as SPO2, heart rate, temperature, blood pressure and water content in the body among several other intelligent diagnostic parameters. Smart phones have made an extremely impressive expansion in terms of applications and can now perform actual diagnostic tests such as the Apple iPhone Glucose test.

The market is highly dynamic and trendy in nature with a heavy importance given to aesthetics and ergonomics of devices. Over 65% of technologies are wrist held devices shaped like watches and the rest include wearability on other areas of the body such as arms, torso and waist. Along with the aesthetics several other features for durability of the device are included such as to make them waterproof and weatherproof. The latest in developments in telecommunication, wireless connectivity and user interface has been applied to these devices to make them more user friendly and keep them easy to interpret even by normal people in order to map their improvement in performance.

Browse the full report with complete TOC: http://www.transparencymarketresearch.com/wearable-medical-devices.html

In 2013, Google Inc. introduced the Google Glass, a wearable eyewear that is highly dynamic and has varied applications throughout all industries. The success of the device at a consumer level is yet to be decided, but the technology has proven to be a boon to hospitals and the medical community for telemedicine and teleradiology. Philips has already launched an ambitious project to equip hospitals with the tech along with its proprietary hospital apps and devices in order to gain a better coverage and increase use of its devices. The device can connect into Philips Intellivue Solutions to quickly transfer crucial information of patient vital signs into the glass where it can be stored inside a 16 GB drive for multiple use, transfer it to another doctor, share it over several continents with a specialized medical expert.

Browse full PDF with TOC: Global Wearable Medical Devices Market- Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The market is expected to remain in strong growth phase as purchase power expands for people in emerging countries of Asia-Pacific and Rest of the World. North America remains in lead for 2012 with a market share of 44%. In terms of competition, the market is highly fragmented and there is no clear leader in terms of revenue considering the whole market. Some of the major market players in the global medical sensors market include Nike, Fitbit, Jawbone, Phyode, Basis Science, Corventis, LifeWatch, Intelesens, Philips, Omron, Zephyr Technology Corporation, Polar Electro, Withings, Sotera Wireless and many more companies each with their own innovative technologies. All in all, this report mentions over 100 companies with a brief emphasis on their technologies.

download-pdf

The global wearable medical devices market is categorized into the following segments:

Wearable Medical Devices Market, by Product Types

    • Wearable TherapeuticMedical Devices
    • Wearable DiagnosticMedical Devices

Wearable Diagnostic Medical Devices Market, by Product Types

    • Vital Signs Monitors
    • Fetal & Obstetric Devices
    • Neuromonitoring Devices

Wearable Therapeutic Medical Devices Market, by Product Types

    • Pain Management
    • Glucose/Insulin Monitoring
    • Respiratory Therapy Devices

Wearable Therapeutic Medical Devices Market, by Application

    • Sports and Fitness
    • Remote Patient Monitoring
    • Home Healthcare

Wearable Medical Devices Market, by Geography

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Advertisements

Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 3.62 Billion Globally in 2019: Transparency Market Research

daniel_riconda-genetic_counselor-winnie_palmer_hospital-non_invasive_prenatal_testing-e1362495343686According to a new market report published by Transparency Market Research, “Non-Invasive Prenatal Testing (NIPT) Market (MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019” the global NIPT market was valued at USD 0.22 billion in 2012 and is expected to grow at a CAGR of 37.6% from 2013 to 2019, to reach an estimated value of USD 3.62 billion in 2019.

The market for non-invasive prenatal testing is evolving rapidly due the advantages it offers over the conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling (CVS). These advantages include safety, accuracy, and no risk of miscarriage. An NIPT is a non-invasive genetic screening test for the common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.) observed in the fetuses of high risk pregnant women (above the age of 35 years). Owing to its ability to detect the presence of chromosomal abnormalities in fetuses of pregnant women as early as 9 to 10 weeks of gestation, the market for non-invasive prenatal testing market is witnessing a rapid increase in demand from all parts of the world.

MaterniT21 PLUS, verifi, Harmony, Panorama, NIFTY, PrenaTest and BambniTest are the commercially available NIPTs in the market which are based on the direct analysis of cell-free fetal DNA in the maternal blood. In 2012, MaterniT21 (a proprietary product of Sequenom, Inc.) accounted for the largest share (36.6%) of the global NIPT market in terms of revenue, owing to the fact that it was the first mover in the market place. During the forecast period 2013 to 2019, it is likely to lose some of its share due to increasing market penetration by other aforementioned NIPTs such as Panorama and verify.

Browse full PDF with TOC: Non-Invasive Prenatal Testing (NIPT) Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

High incidence rate of babies born with certain type of chromosomal abnormalities, growing trend of child bearing at advanced maternal age and enhanced popularity of NIPT among gynecologists and high risk pregnant women are some of the major factors anticipated to drive growth of the NIPT market during the forecast period. Some of the most commonly detected chromosomal aneuploidies include Down syndrome, Edwards syndrome, Patau syndrome and monosomy X. On the other hand, ethical and regulatory hurdles are expected to pose significant challenges before the NIPT market to grow. Various professional committees across the world believe that the implementation of NIPT and the subsequent rise in uptake of prenatal testing is likely to increase the incidence of abortions. Therefore, professional groups such as The American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics and Gynecology have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.

download-pdf

Geographically, North America was the largest regional market in 2012 with a market share of 64.5% of the total revenue generated globally, followed by Europe. Almost every company operating in this market is adopting the same business model of marketing their tests via alliances with hospitals, diagnostic laboratories and physician offices. The increasing penetration by test developers in European, Asia-Pacific and Middle-East countries indicates promising growth in the near future in these markets. Sequenom, Inc., Verinata Health, Inc. (now a part of Illumina, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Health, LifeCodexx and Berry Genomics are the companies engaged in providing non-invasive prenatal tests worldwide.

The global non-invasive prenatal testing market is segmented as follows:

Non-Invasive Prenatal Testing Market, by Test

  • MaterniT21 PLUS
  • verifi
  • Harmony
  • Panorama
  • NIFTY
  • PrenaTest
  • BambniTest

Non-Invasive Prenatal Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Contact:

Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Browse more market research reports: Transparency Market Research

Cord Blood Banking Services Market is Expected to Reach USD 15.2 Billion Globally in 2019: Transparency Market Research

Cord Blood Banking Services MarketAccording to a new market report published by Transparency Market Research, Cord Blood Banking Services Market (Private and Public Cord Blood Banks)  Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013  2019″, the global cord blood banking services market was valued at USD 12.40 billion in 2012 and is expected to grow at a CAGR of 5.6% from 2013 to 2019, to reach an estimated value of USD 15.23 billion in 2019.

Cord blood banking (CBB) is one of the fastest growing segments of the healthcare industry. Factors such as increasing awareness, initiatives taken by governments to regulate the CBB industry, an increasing number of diseases that can be treated using stem cell therapy and growing concerns about developing worldwide cord blood inventory will have an impact on the current model of the cord blood banking industry.

The global cord blood banking services market is segmented on the basis of type of service vendor and geography. Based on service vendor type the cord blood banking market is classified into private cord blood banks and public cord blood banks. The market share of private cord blood banks is larger than the public cord blood banks as private banks charge the service right from the collection of the cord blood followed by storage and processing charges, spends more on advertising and incentives as compared to public banks. It is expected that the global market for private banks will reach USD 11.58 billion in 2019 with the market growing at CAGR of 1.9% from 2013 to 2019. The shift from storing cord blood in private banks to public banks is growing the market share of public cord blood banks globally.

The United States, and some of the European countries such as the U.K. and Spain, are leading in cord blood banking services. Asian countries like China and India are emerging markets with higher population growth rate. UAE, Qatar and Saudi Arabia are some of the lucrative markets in RoW.

North America currently dominates the market but in future developing countries in Asia will lead the market. Growth drivers in the North American market are increasing awareness about the cord blood banking services, stem cell therapy and affordable cost.

Cord Blood Banking Services Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Some of the key market players operating in this market include Cord Blood America, Inc., NeoStem, Inc., Cryo-Cell International, Inc., Cord Blood Registry Systems, Inc. and China Cord Blood Corporation.

The global cord blood banking services market is segmented as follows:

  • Based on Type of Service Vendor
    • Private cord blood banks
    • Public cord blood banks
  • Based on Geography
    • North America
      • United States
      • Canada
    • Europe
      • UK
      • Spain
      • France
      • Germany
      • Italy
      • Belgium
    • Asia-Pacific
      • India
      • China
      • Japan
      • Australia
      • New Zealand
      • Philippines
    • Rest of the World
      • Brazil
      • Argentina
      • Middle Eastern Countries
      • Russia

Browse more reports: Transparency Market Research

Transparency Market Research: Drugs Abuse Testing Market New Analysis Report

Drugs of Abuse Testing MarketAccording to a new market report published by Transparency Market Research “Drugs of Abuse Testing Market (Sample Based Testing – Urine, Saliva and Hair Onsite and laboratory Testing) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018” the global drugs of abuse testing market was valued at USD 2.6 billion in 2012 and is expected to grow at a CAGR of 4.8% from 2013 to 2018, to reach an estimated value of USD 3.4 billion in 2018.

Browse the full Report with TOChttp://www.transparencymarketresearch.com/drugs-abuse-testing-market.html

In various countries, government rules & regulations are supporting drugs of abuse testing market to grow, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. As a result, this market is expected to grow at a CAGR of about 4.8% during 2013 – 2018.

Some of the key driving factors for the drugs of abuse testing market are global rising consumption of illicit drugs, adoption of drug of abuse (DOA) testing at organizational level, increased production of illicit drugs and their trade and increasing death rates/road accidents due to drug abuse. However, the market faces some restraints such as social concerns associated with illicit drugs testing, legalization of various drugs, and economic volatility and cost concerns.

North America, including the US has the largest drugs of abuse testing market and is also the fastest growing drugs of abuse testing market. Some of the fastest growing markets for drugs of abuse testing are US, UK, Japan, Germany and other European countries. According to UNODC report 2013, number of illicit drug users is estimated to increase from 167 million in 2009 to 315 million people in 2011. This corresponds to 3.6% to 6.9% of global adult population and cannabis, opioids and opiates were most commonly used illicit drugs. In various countries, including America and Europe countries, organizations are conducting drug screening test at various levels, such as pre-employment screening, random drug/alcohol screening, post incident drug/alcohol screening and abstinence monitoring. In many countries, government rules & regulations are also supporting the growth of drugs of abuse testing market, as they have outlined essential drug testing at workplace, such as in the US, Japan, Australia and the UK. This has emerged as a key driver for the market.

Browse full PDF wih TOC: Drugs of Abuse Testing Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Urine is the largest sample which is diagnosed in the drugs of abuse testing market and it is expected to grow at a CAGR of about XX% during 2013 – 2018. The other major samples for drugs of abuse testing are Saliva and Hair. Laboratory drug screening test requires a trained and skilled person to provide an accurate result and involves in-depth analysis. In laboratory screening test, usually the test is reconfirmed using gas chromatography/mass spectrometry or any other superior techniques to provide accurate results. On-site drug screening test gives results on the spot and it is generally preferred for those who take the drug test at home, workplace and educational institutions. The most common specimens used in on-site drug testing are urine, saliva and hair. Nowadays, commercially-available on-site screening test kits are usually designed for urine and saliva specimens only.

Roche Diagnostics is the leading player in the global drugs of abuse testing market. Other major players of drugs of abuse testing market include Quest Diagnostics, LabCorp, Alere and Abbott Laboratories and others.

The global drugs of abuse testing market is segmented as follows:

Drugs of Abuse Testing Market, By Sample

  • Urine
  • Saliva
  • Hair

Drugs of Abuse Testing Market, By Types

  • Laboratory Drug Test
  • On-site Screening Test

Drugs of Abuse Testing Market, by Geography

  • North America
  • US
  • Europe
  • UK
  • Germany
  • France
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of the World (RoW)

Power Rental Market by Transparency Market Research

Power Rental MarketAccording to a new market report published by Transparency Market Research “Power Rental Market for applications (Peak Shaving, Continuous Power and Standby) in End Use (Government and Utilities, Oil, Gas and Mining, Construction, Industrial, Events) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2019” the global power rental market was valued at USD 7.28 billion in 2012 and is expected to reach 20.64 billion in 2019, growing at a CAGR of 16.2% from 2013 to 2019.

Browse the full Power Rental Market Report with TOC: http://www.transparencymarketresearch.com/power-rental-market.html

Growing energy demand and increased grid instability is one of the key factors attributed to power rental market growth. Furthermore, increasing alternating power spikes coupled with rising number of planned and unplanned events are expected to augment market growth. Rising awareness amongst energy intensive industries to curtail growing energy demand during peak hours is likely to bolster the product demand. Key challenges faced by the market participants include stringent environmental regulations against diesel power generators, which are expected to curb market growth. However, development of evolutionary power rental systems is hopeful to overcome the challenge. Growing demand arising in off grid regions is expected to generate new opportunities for the market owing to its convenient portability to remote off grid areas.

Key applications analyzed in this market include peak shaving, continuous power and standby market. The continuous power application market held a significant share in the overall market followed by peak shaving and standby applications in 2012. The growing popularity of peak shaving applications is likely to boost the product demand over the forecast period. The peak shaving application market is likely to grow at a CAGR 16.8% from 2013 to 2019. Regulatory intervention by Greenpeace over the energy consumption is expected to trim the product demand in standby application market over the coming years.

The Middle East and Africa (MEA) dominated global power rental market in 2012, accounting for more than 31% of the overall market in 2012. Asia Pacific followed MEA accounting for more than 19% market share in 2012. Rising energy demand in MEA is expected to bolster the overall market growth. Asia Pacific and MEA regions are expected to witness a surge in power rental systems demand owing to rise in electricity requirement. MEA power rental market is estimated to reach USD 6.87 billion by 2019 while Asia Pacific market is expected to grow at a CAGR of 16.8% from 2013 to 2019. Key participants in this market include Aggreko plc, APR Energy LLC, Atlas Copco AB, and Energyst CAT Rental Power. Aggreko plc dominated power rental market in 2012 owing to their global presence and strong distribution network. The report provides an overview of these companies followed by their financial revenue, business strategies, and recent developments.

Browse full PDF with TOC: Power Rental Market for applications- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2019

This research analyzes and estimates the performance and market of power rental systems in the global scenario, providing detailed trend analysis of the market by geography and comprehensive analysis of companies that are dealing in power rental systems. The report presents a thorough assessment of the strategies followed by different stakeholders by segmenting the power rental market as below:

Power Rental Market: Application Analysis

  • Peak Shaving
  • Continuous Power
  • Standby
  • Power Rental Systems Market: End User Analysis
  • Government and Utilities
  • Oil, Gas and Mining
  • Construction
  • Industrial
  • Events

Power Rental Market: Regional Analysis

  • North Americas
  • Europe
  • Asia-Pacific

Global Caprolactam Market New Published Report by Transparency Market Research

Transparency Market ResearchTransparency Market Research has released a new market report titled “Caprolactam (Nylon 6 Fiber and Nylon 6 Resin) Market For Textiles, Carpets, Industrial Yarns, Engineering Plastics, Packaging, Electronics and Other Applications – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019,” which observes that the caprolactam demand in 2012 was worth USD 8.66 billion and is expected to reach USD 13.80 billion by 2019, growing at a CAGR of 6.9% from 2013 to 2019. In terms of volume, the demand for caprolactam was 3,580.0 kilo tons in 2012.

Browse the full Report with TOC: http://www.transparencymarketresearch.com/caprolactam-market.html

Caprolactam is an important polymer having host of applications across different industries. Caprolactam is the key raw material for nylon 6. Caprolactam is used to produce nylon 6 fibers and resins that are used extensively in various applications. The growing demand of nylon 6 in engineering and automobile applications as well as rapid economic growth in Asia Pacific is expected to remain the major driving force for the caprolactam market. Volatile raw material prices are expected to be a key challenge for market participants.

Nylon 6 fibers dominated the consumption of caprolactam and accounted for over 66% of total demand in 2012. Superior chemical as well as physical characteristics such as light weight and high tensile strength, nylon 6 fibers have become materials of choice in various textile and carpets application. The use of caprolactam in nylon 6 resin production employed in engineering plastics and electronic applications is anticipated to be the major growth market over the next few years. Similar surge in demand is expected to be witnessed from industrial yarn applications where nylon 6 fibers are used as tire cords for enhanced wear resistance and high strength characteristics.

Asia Pacific accounted for about 51% of the total caprolactam market in 2012, followed by Europe and North America. Asia Pacific is also expected to be the fastest growing regional market in terms of both caprolactam consumption and production. This can be attributed to the growing economies in this region. Skilled labor, cheap availability of raw materials, equipments, and land has resulted in Asia Pacific emerging as a key destination for caprolactam producers. Recently various manufacturers have concentrated on capacity expansion in Asia Pacific to increase their production capacities. Europe is the other major region where caprolactam consumption was very strong and is expected to grow in demand with a CAGR of about 6.4% in terms of volume from 2013 and 2019.

DSM, BASF SE, Honeywell, Ube Industries and Capro Corporation are some of the major participants in the caprolactam industry.

Browse full PDF with TOC: Caprolactam Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 – 2019

Caprolactam Market – Product Segment Analysis

  • Nylon 6 fiber
  • Nylon 6 resin

Caprolactam Market – Application Segment Analysis

  • Nylon 6 fiber
  • Textiles
  • Carpet
  • Industrial yarns
  • Others (fishing lines, fishing nets, bristles, surgical suture, etc.)
  • Nylon 6 resin
  • Engineering plastic
  • Packaging
  • Electronics
  • Others (musical strings, composites, lysine synthesis, etc.)

Caprolactam Market – Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

Ophthalmic Drugs Market is Expected to Reach USD 21.6 Billion Globally in 2018: Transparency Market Research

Ophthalmic Drugs MarketAccording to a new market report published by Transparency Market Research “Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti allergy/ inflammatory/ infective, Retinal Drugs) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018” the global ophthalmic drugs market was valued at USD 16 billion in 2012 and is expected to grow at a CAGR of 5.2% from 2013 to 2018, to reach an estimated value of USD 21.6 billion in 2018.

Browse the full Report with TOC: http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

Globally, the ophthalmic drugs market is witnessing significant growth due to increasing prevalence of eye disorders such as diabetic retinopathy and macular degeneration. As a result, this market is expected to grow at a CAGR of about 5.2% during 2013 – 2018.

Some of the key driving factors for the ophthalmic drugs market are rising prevalence of global aging population, increasing government initiatives towards healthcare infrastructure in developing countries (such as India and China), technological changes in drug delivery technique, and increasing prevalence of lifestyle associated diseases. However, the market faces some restraints such as lack of awareness among people regarding eye disorders, drying pipeline of ophthalmic drugs, patent expiration of blockbuster ophthalmic drugs and absence of health insurance in developing countries.

download-pdf

North America, including the US has the largest ophthalmic drugs market. Asia is the fastest growing ophthalmic drugs market. Some of the fastest growing markets for ophthalmic drugs are China, India, other countries in South East Asia and the Eastern Mediterranean. As per WHO estimates in 2010, in the next nine years, the number of blind people aged 50 years and above will grow in these regions, thereby increasing the demand for ophthalmic drugs. On the other hand, in developed regions such as North America and Western Europe, rising efforts towards prevention of blindness among the aging population has emerged as a key driver for the market.

Browse full PDF with TOC: Ophthalmic Drugs Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2018

Glaucoma has the largest market share in the ophthalmic drugs market and it is expected to grow at a CAGR of about 4.2% during 2013 – 2018. Various ophthalmic drug companies are increasing their focus on combination therapy, which involves use of more than one medication for specific retinal disorders. Most of these combination therapies are used as first line treatment in patients with high level of intraocular pressure. Combination therapy has various advantages over traditional medication such as reduced frequency of eye drop application, improved patient compliance and efficacy.

Novartis (Alcon) is the leading player in the global ophthalmic drugs market while other major players include Allergan, Santen, Pfizer, Merck and Roche.

The global ophthalmic drugs market is segmented as follows:

Ophthalmic Drugs Market, By Treatment Drugs

  • Dry Eye Drugs
  • Retinal Drugs
  • Anti-inflammatory/allergy/infective Drugs
  • Anti-glaucoma Drugs

Ophthalmic Drugs Market, By Types

  • Prescription Drugs
  • OTC Drugs

Ophthalmic Drugs Market, by Geography

  • North America
  • US
  • Europe
  • Germany
  • UK
  • France
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research